Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres








Gamme d'année
1.
Article de Chinois | WPRIM | ID: wpr-331721

RÉSUMÉ

<p><b>OBJECTIVE</b>To explore the protective effect and mechanism of ligustrazine (LGT) and propofol (PRO) on peri-operational liver ischemia-reperfusion injury (HIRI).</p><p><b>METHODS</b>Thirty-six patients scheduled for hepatic surgery were randomly divided into the control group, the LGT group, the PRO group and the LGT + PRO group, 9 patients in each group. Changes of superoxide dismutase (SOD), lipid peroxide (LPO), ratio of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha), alanine aminotransferase (ALT) activity, and the ultrastructure of liver tissue were dynamically observed.</p><p><b>RESULTS</b>Compared with the control group, SOD activity was significantly higher, LPO concentration, TXB2/6-keto-PGF1alpha ratio and ALT value were significantly lower (P < 0.05 and P < 0.01) in the LGT group, the PRO group and the LGT + PRO group during HIRI, with the abnormal changes of hepatic ultrastructure 25 min after reperfusion significantly alleviated in the three treated group.</p><p><b>CONCLUSION</b>Combination of ligustrazine and propofol shows protective effect on liver by decreasing oxygen free radical level, reducing lipid peroxidation and adjusting TXA2/PGI2 imbalance after hepatic ischemia-reperfusion in patients undergoing hepatic cancer surgery.</p>


Sujet(s)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , 6-Cétoprostaglandine Fl alpha , Sang , Association de médicaments , Peroxydes lipidiques , Sang , Foie , Tumeurs du foie , Chirurgie générale , Propofol , Utilisations thérapeutiques , Pyrazines , Utilisations thérapeutiques , Lésion d'ischémie-reperfusion , Superoxide dismutase , Sang
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE